Venture Capital News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Venture CapitalNewsAspen Neuroscience Lands $115M Series C
Aspen Neuroscience Lands $115M Series C
Venture Capital

Aspen Neuroscience Lands $115M Series C

•November 20, 2025
0
VC News Daily
VC News Daily•Nov 20, 2025

Companies Mentioned

Aspen Neuroscience

Aspen Neuroscience

ARCH Venture Partners

ARCH Venture Partners

Revelation Partners

Revelation Partners

OrbiMed

OrbiMed

Frazier Life Sciences

Frazier Life Sciences

Medical Excellence Capital

Medical Excellence Capital

BAM

BAM

S32

S32

Lifeforce Capital

Lifeforce Capital

Lyfe Capital

Lyfe Capital

Why It Matters

The infusion of $115 million accelerates development of a potentially disease‑modifying Parkinson’s treatment, positioning Aspen as a frontrunner in personalized regenerative therapy and attracting further biotech investment in the neuro‑degeneration space.

Aspen Neuroscience Lands $115M Series C

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...